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Periodontitis, a multifactorial infection-induced low-grade chronic inflammation, can influence the process of carcinogenesis.
We studied with 10 years follow-up of 68,273 adults-based cohort the involvement of periodontitis as a risk factor for cancer
mortality. Periodontal status was defined based on procedure codes of periodontal treatment. Rate ratios and absolute differ-
ences of overall and cancer mortality rates were assessed with respect to periodontal status using multiplicative and additive
Poisson regression models, respectively. We adjusted for effect of age, sex, calendar time, socio-economic status, oral health,
dental treatments and diabetes. Data about smoking or alcohol consumption were not available. Altogether 797 cancer deaths
occurred during 664,020 person-years accumulated over a mean 10.1-year follow-up. Crude cancer mortality rate per 10,000
person-years for participants without and with periodontitis was 11.36 (95% CI 10.47–12.31) and 14.45 (95% CI 12.51–
16.61), respectively. Crude rate ratios for periodontitis indicated an increased risk of overall (RR 1.27, 95% CI 1.08–1.39) and
pancreatic cancer (RR 1.69, 95% CI 1.04–2.76) mortality. After adjustment, the results showed even stronger associations of
periodontitis with increased overall (RR 1.33, 95% CI 1.10–1.58) and pancreatic cancer (RR 2.32, 95% CI 1.31–3.98) mortality.
A higher pancreatic cancer mortality among individuals with periodontitis contributed considerably to the difference in overall
cancer mortality, but this difference was not due to pancreatic cancer deaths alone.
Periodontitis, a multifactorial infection-induced inflamma-
tion, results in loss of connective tissue attachment and bone
support of teeth and is a major cause of tooth loss in adults.
Worldwide estimates for the prevalence of severe periodontal
disease generally range from 10% to 15%.1
In addition to pathogenic microorganisms in the biofilm,
genetic and environmental factors, including age, race, male
sex, body mass index, tobacco, diabetes, nutrition, and
populations with low socio-economic status and those with
limited access to dental care, eventually contribute to the
onset and course of periodontal diseases.2 The impact of dia-
betes mellitus on periodontitis has been shown to be inde-
pendent of the other major risk factors.3
In periodontitis, pathogenic microorganisms interact with
host tissues and cells, causing the release of a broad array of
inflammatory cytokines, chemokines, proteolytic enzymes,
reactive oxygen species and other mediators that lead to local
irreversible degeneration of the periodontal structures. The
systemic dissemination of infectious agents and inflammatory
mediators from the oral environment may cause an elevated
and sustained systemic inflammatory condition, which may
promote the pathogenesis of distal inflammatory processes
such as the pathogenesis of cancer. Research in the field of
periodontology has focused on the potential of this chronic
low-grade inflammatory condition to contribute to the gener-
ation of a systemic inflammatory phenotype.4 The impor-
tance of periodontal infections to systemic health is further
strengthened by pilot intervention trials indicating that peri-
odontal therapy can prevent and reverse systemic adverse
events, for example, improving surrogate cardiovascular out-
comes, such as endothelial function, and reducing proinflam-
matory biomarkers.5
Infection-driven inflammations have been estimated to be
involved in the pathogenesis of 15% of human tumors.
Globally in 2012, an estimated 14 million new cancer cases
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occurred, 2.2 million of which were attributable to carcino-
genic infections.6 In some types of cancer, inflammatory con-
ditions are present before a malignant change occurs.
Conversely, in other types of cancer, an oncogenic change
induces an inflammatory microenvironment that promotes
the development of tumours.7 Several epidemiological studies
have suggested a positive association between periodontal dis-
ease and carcinogenesis risk in different tissues, most notably
in the mouth, upper gastrointestinal system, lung and pan-
creas, underpinned by immune-inflammatory mechanisms
common to both entities.8–10
A few studies also exist on periodontitis and the morbidity
and mortality associated with human cancers. Epidemiologi-
cal studies have explored possible relationships between tooth
loss/periodontitis and total mortality, all kinds of cancer and
cancers of the oral cavity and pharynx, esophagus, stomach,
pancreas, liver, colon, rectum, and anus, unadjusted or
adjusted for age, gender, socio-economic status, smoking hab-
its, vitamin A and C consumption and alcohol intake.11–13
Our aim was to investigate the relationship between peri-
odontitis and cancer mortality by conducting a historic
cohort study in a population of primary dental care patients.
We utilized the high quality and coverage of the Finnish
health care register data.
Methods
Study population
We used the data from the patient register of the Public Den-
tal Service of the City of Helsinki to identify all individuals
aged 29 years or more with at least one primary dental health
care visit between 1 January 2001 and 31 December 2002.
For these patients, follow-up data on deaths and causes of
death were obtained from the register of deaths of Statistics
Finland14 through a computerized register linkage using the
unique personal identification codes assigned to every resi-
dent in Finland. Along with the date of death, mortality data
also included the cause of death coded according to the tenth
revision of the International Classification of Diseases (ICD-
10). In addition, data on socio-economic status and education
were obtained from Statistics Finland. The dental care data
were also linked to the Drug Reimbursement Register of the
Finnish Social Insurance Institution (SII). These drug pre-
scription records cover the entire study population, except
for institutionalized patients. In Finland, patients with
chronic or severe disease, such as diabetes, are granted special
reimbursement rights for outpatient medical treatment based
on a physician statement on their condition and need for
medication.15 The cancer diagnosis data, date of diagnosis
and ICD-O-3 code16 were obtained from the Finnish Cancer
Registry (FCR). The FCR database contains data on virtually
all cancers diagnosed in Finland since 1953. The coverage
and accuracy of the Finnish Cancer Registry data are
excellent.17,18
Altogether 71,200 patients visited the Public Dental Ser-
vice of Helsinki in 2001–2002. We restricted the study popu-
lation to those who had no history of cancer at the first visit
and who were alive two years after the first visit (Fig. 1). The
size of the final study population was 68,273 individuals. The
follow-up for mortality started two years after the first visit
and continued until 31 December 2013 or death, whichever
occurred first.
Outcomes
The outcomes of interest were mortality from any cancer and
nine cancer types defined by topology (ICD-O-3): lung
(C33–34), breast (C50), pancreas (C25), upper gastrointesti-
nal (C15–17), esophageal (C15), gastric (C16), liver (C22),
head and neck (C00–C14) and prostate (C61). Most of these
outcomes were included based on current epidemiological
evidence, while the mortality from lung or liver cancer was
selected to check whether the relationship between periodon-
titis and cancer mortality could be confounded by smoking
and/or use of alcohol, which are known to be associated with
both periodontitis and risk of cancer, but data of these expo-
sures are not available in the register data.
Measure of exposure and potential confounders
We utilized data from dental visits within a period starting 2
years after the first visit. Dentists use the classification of the
Finnish Social Insurance Institution (KELA) to record treat-
ment measures provided, and these codes were used here to
detect periodontal disease. These data include procedure
codes of dental treatment (gingivitis, periodontitis, caries,
endodontic, surgery and prosthesis) and information on den-
tal status presented by number of teeth, oral health indices,
such as primary caries (I), number of decayed teeth (DT),
decayed/missing/filled teeth (DMFT) and need for periodon-
tal treatment due to periodontal pockets (CPI5 the Commu-
nity Periodontal Index). Exposure to periodontitis was
What’s new?
Periodontitis is characterized by infection-driven inflammation, a type of inflammation that is a factor in about 15% of human
tumors. It remains unclear, however, whether periodontitis increases cancer risk or influences cancer mortality. In this study,
long-term follow-up on a large cohort of dental patients in Finland suggests that periodontitis is associated with increased
overall cancer mortality, especially increased mortality from pancreatic cancer. The findings suggest that the prevention and
treatment of periodontitis can help reduce the risk of systemic adverse events, such as death, from cancer.
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defined as a binary variable (no/yes) based on periodontitis
treatment procedure codes.19,20
Among potential confounders in this study were socio-
demographic characteristics, such as age, sex and socio-
economic status, which were available for the entire study
population. We used age (<40, 40–50, 50–60, 60–70, >70)
and calendar time (<2006, 2006–2009, 2010) as time-
dependent covariates. Data on profession obtained from Sta-
tistics Finland were categorized into eight broader categories
(lower-level employees, upper-level employees, manual work-
ers, pensioners, students, self-employed or employers, unem-
ployed and unknown) to represent socio-economic status. In
addition, we used prescription data to identify patients with
diabetes, which is known to affect the risk for both periodon-
titis and cancer. We defined diabetes as use of any anti-
diabetic medication (ATC-codes beginning with A10) based
on prescription before the start of follow-up. To account for
dental status other than periodontitis, we used number of
teeth (0–23, 24–27, 28–32), indices I (0, 1–2, 3–4, 5), DT
(0, 1–2, 3–4, 5), DMFT (0–13, 14–18, 19–23, 24 accord-
ing to quartiles) and CPI (0–1, 2, 3–4), number of healthy
sextants (0, 1, 2–4, 5–6), number of toothless sextants (0, 1–
6), and indicators of different dental treatments (yes/no).19,20
I, DT, DMFT and CPI indices were defined by taking the
maximum value of those recorded during the dental visits
within two years after the first visit. Number of healthy sex-
tants was specified according to that of the first visit, and
number of toothless sextants by selecting the minimum value.
For part of the study population, however, information on
health indices was not available because it is not routinely
recorded at every visit; these appointments were defined as
follow-up visits. Thus, we defined these covariates included a
missing data category.
Statistical analyses
The individual follow-up period was split into the smaller
bands using Lexis tabulation in R programming language.21,22
For each outcome of interest, we calculated the crude mortal-
ity rates (MRs) as number of cases divided by person-time at
risk along with exact confidence intervals based on Poisson
rates. We also assessed age-standardized mortality rates
(ASMRs) using weights according to the World Standard
Population (1960).
For each outcome of interest, we calculated both absolute
and relative differences to compare the MR between individ-
uals with and without periodontitis. Mortality rate ratios
(MRRs) and 95% confidence intervals (CIs) were estimated
by fitting a multiplicative Poisson regression model to the
numbers of events using the logarithm of person-years as an
offset. Absolute rate differences (ARDs) along with 95% CIs
were calculated by applying an additive Poisson regression
model to the incidence rates with person-years as weights.23
In these analyses, death from causes other than the cancer of
interest were treated as censored. Crude and adjusted differ-
ences were evaluated using univariate and multivariate Pois-
son models, respectively. Through adjustment, we controlled
in Model 1 for the effect of socio-demographic factors
(period, age, sex and occupational status), and in Model 2,
additionally, for number of teeth, oral health indices (I, D,
DMF), need for periodontal treatment and diabetes.
In addition, by using the fully adjusted estimates of ARD,
we calculated number-needed-to-harm (NNH), which is an
inverse of ARD and indicates the number of patients on
average needing to be exposed to periodontitis to cause the
death of one patient who would otherwise have stayed alive.
Sensitivity analyses
Robustness of results was checked by performing sensitivity
analysis. In the primary analysis, we analyzed the entire
cohort, which included also individuals with missing observa-
tions for some covariates. To check whether the differences
in mortality rates were similar among individuals with com-
plete observations (i.e., data missing at random), we analyzed
individuals with complete data. We also investigated whether
the change in the definition of periodontitis affects the
results. In addition to periodontitis procedure codes, which
were used in the main analysis to define periodontal status, a
periodontal pocket depth of >3 mm was also interpreted as
periodontitis. We then evaluated the effect of this new expo-
sure variable on mortality rates. We used the version 3.2.2 of
R21 and the Epi24 package to perform all analyses.
Patient involvement
No patients were involved in setting the research question or
the outcome measures, nor were they involved in
Figure 1. The flowchart of the study. Altogether 71,200 patients
visited the Public Dental Service of Helsinki in 2001–2002. We
restricted the study population to those who had no history of can-
cer at the first visit and who were alive for 2 years after the first
visit. The size of the final study population was 68,273 individuals.
The follow-up started 2 years after the first visit and continued
until 31 December 2013 or death, whichever occurred first.
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recruitment, design or implementation of the study. Patients
were not asked to interpret or disseminate results.
Results
The study population included 68,273 patients who had
cumulated 664,020 person-years (PYs) over a median follow-
up of 10.1 years (Table 1). The mean age of the population
at baseline was 43 years, and the slight majority was females
(58%). The mean number of teeth was 27.6, but that infor-
mation was not available for 19,633 patients (28.8%). The
reason for missing information is that the whole oral health
status is not always routinely checked when a patient visits
the dentist because of an accident or emergency. Endodontic
treatment was the most common procedure, affecting 70.3%
of all patients, whereas only 40.6% were treated for gingivitis
and 20.5% for periodontitis.
During the 10-year follow-up, 797 cancer deaths occurred.
The total number of deaths was 5,434; thus, deaths due to
cancer comprised 14.7% of all deaths. Of all cancer deaths,
199 (25%) were observed in patients with periodontitis, for
which the crude cancer MR was 14.45 per 10000 person-
years (95% CI 12.51–16.61), while for patients without peri-
odontitis, the crude MR was 11.36 (95% CI 10.47–12.31).
Lung cancer was the most common diagnosis in cancer mor-
tality, with a crude MR of 2.42 (95% CI 2.06–2.83), followed
by cancers of the breast (crude MR5 1.89, 95% CI 1.48–
2.37), pancreas (1.13, 95% CI 0.89–1.42) and prostate (0.95,
95% CI 0.62–1.40).
Age-standardized cancer mortality rates in our study were
similar to the rates for the general population of Helsinki
reported by the FCR for the period 2008–2012 (Table 2). The
absolute and relative differences in cancer mortality rates
between individuals with and without periodontitis are pre-
sented in Table 3. Based on both absolute and relative rate
differences, a significantly increased overall cancer mortality
was associated with periodontitis. Comparison of MRs on the
relative scale yielded a crude MRR of 1.27 (95% CI 1.08–
1.86), while a crude ARD of 3.01/10,000 person-years (0.89,
5.30) was observed when comparing mortality rates on the
absolute scale. These differences remained significant after
adjustment for the available demographic risk factors (Model
1) and further adjustment for diabetes and oral health indices
(Model 2), yielding MRR of 1.32 (1.10, 1.58) and ARD of
6.54 (2.48, 10.61) in this fully adjusted model. When compar-
ing site-specific cancer mortality rates among patients with
and without periodontitis, the results indicated a twofold risk
of death due to pancreatic cancer on the relative scale (Model
2: MRR 2.28, 95% CI 1.31–3.98), but no significant difference
on the absolute scale (Table 3).
For other cancer types, no significant differences were
found on either the absolute or the relative scale, when per-
forming comparisons of mortality rates by periodontal status.
The adjusted ARD in overall cancer mortality between people
with and without periodontitis was 6.54 (2.48–10.61) per
10000 person-years, which gives number-needed-to-harm
(NNH5 1/ADR) of 1529 (942–4,032) for periodontitis.
The results of the main analysis were robust across the
sensitivity analyses performed (Supporting Information,
Table/Data not shown). After exclusion of individuals with
missing observations (29%), the association between peri-
odontitis and excess overall (fully adjusted MRR 1.26, 95%
CI 1.03–1.55) and pancreatic (2.05, 95% CI 1.05–3.99) cancer
mortality persisted. After expanding the periodontitis status
to incorporate also gum pockets of a depth of >3 mm, a
total of 20,269 individuals were interpreted as having peri-
odontitis. Comparisons of mortality rates performed accord-
ing to this division yielded similar results for overall (1.36,
1.09–1.71) and pancreatic cancer (2.32, 95% CI 1.24–4.37)
mortality.
Discussion
Our study with a long follow-up (10 years) of a large
population-based cohort (n5 68,273) showed a clear positive
association between periodontitis and cancer mortality, espe-
cially pancreatic cancer mortality.
Strengths and limitations of this study
Strengths of our study are the large, relatively unselected
population and the long follow-up time. The study popula-
tion consisted of patients with at least one visit to dental
health care of the City of Helsinki, that is, individuals with-
out any of the aforementioned dental visits were not eligible
for the study. In principle, this noneligible population
includes people without any dental visits and those utilizing
only the private sector dental health care. Usage of private
health care may have caused some selection of the study pop-
ulation because about 36% of dental care was covered by it
in the study period.25 On the other hand, observed standard-
ized mortality rates in our study were quite similar to the
rates of the entire City of Helsinki population. This means
that it is not very probable that population selection would
have had a large impact on study results.
The strength of the exposure data in our study is that it
contained detailed clinical information about oral health and
dental procedures. On the other hand, a limitation of our
data is that a large proportion of dental status data is miss-
ing, that is, for 28% of the study population, the number of
teeth was not known. In statistical analyses, missing informa-
tion was treated as a separate category that was probably ade-
quate for adjusting purposes. Our primary exposure—
periodontal status—was determined by procedure codes,
which means that the number of false positives is very low.
Connected to this, there are many false negatives, that is,
people with periodontitis who were not treated. However, it
is reasonable to assume that these false negatives tend to
have less severe periodontitis, and thus, the potential bias
caused by false negatives can be considered to be relatively
small.
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Table 1. Basic characteristics of the study population of 68,273 patients
Periodontitis treatment, N514,021 No periodontitis treatment, N554,252
Sex, male N (%) 6,461 (46.1) 21,719 (40.0)
Age, mean (SD), years 43.6 (9.8) 43.0 (12.1)
Age groups, N (%)
30–39 7,483 (53.4) 34,372 (63.4)
40–49 4,043 (28.8) 11,315 (20.8)
50–59 1,922 (13.7) 4,546 (8.4)
60–69 224 (1.6) 1,191 (2.2)
70 349 (2.5) 2,828 (5.2)
Median follow-up time (IQR) 10.0 (9.6, 10.6) 10.1 (9.5, 10.7)
Person-years (1/10,000) 13.8 52.6
Socio-economic status, N (%)
Lower level employees 4,199 (29.9) 16,358 (30.1)
Upper level employees 2,382 (17.0) 11,022 (20.3)
Manual workers 2,869 (20.5) 9,409 (17.3)
Pensioners 1,376 (9.8) 6,104 (11.3)
Students 399 (2.9) 1,774 (3.3)
Self-employed or employers 457 (3.3) 1,576 (2.9)
Unemployed 1,545 (11.0) 4,971 (9.2)
Unknown 794 (5.6) 3,038 (5.6)
Number of teeth, mean (SD) 27.7 (3.9) 27.5 (5.1)
Number of teeth, N (%)
28–32 8,307 (59.3) 25,819 (47.6)
24–27 2,902 (20.1) 6,708 (12.4)
0–23 1,302 (9.3) 3,602 (6.6)
Missing 1,510 (10.8) 18,123 (33.4)
Treatment, N (%)
Caries 3,034 (21.6) 8,854 (16.3)
Endodontic 11,226 (80.1) 36,758 (67.8)
Gingivitis 5,042 (36.0) 22,672 (41.8)
Prosthesis 712 (5.1) 2,359 (4.4)
Surgery 3,846 (27.4) 11,259 (20.8)
I index,1 N (%)
0 2,942 (21.0) 9,983 (18.4)
1–2 3,811 (27.2) 11,118 (20.5)
3–4 2,428 (17.3) 6,504 (12.0)
5 3,336 (23.8) 8,584 (15.8)
Missing 1,504 (10.7) 18,063 (33.3)
D index,1 N (%)
0 3,970 (28.3) 15,072 (27.8)
1–2 4,666 (33.3) 12,695 (23.4)
3–4 2,029 (14.5) 4,471 (8.2)
5 1,859 (13.2) 3,977 (7.3)
Missing 1,497 (10.7) 18,037 (33.3)
DMF index,1 N (%)
0–13 2,992 (21.3) 10,629 (19.6)
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Studies investigating the association between periodontal
disease and cancer have used a variety of measures to define
periodontal disease and the manner in which disease progres-
sion is ascertained. There is no standardized definition or
clinical criteria for periodontal disease in periodontal epide-
miological research, hindering comparisons of studies exam-
ining the association between periodontal disease and
cancer.26 Periodontal disease is generally diagnosed by prob-
ing and measuring alveolar bone height with radiographs. As
periodontitis is a primary cause of tooth loss in adults, the
number of lost adult teeth has also been used as a marker of
periodontal disease in epidemiological literature. Tooth loss
at an older age is more likely to be caused by chronic peri-
odontal disease, while tooth loss at younger ages is probably
the result of dental caries.27 Assessing the presence of peri-
odontal disease by extent of tooth loss alone may be inade-
quate to examine the link between periodontal disease and
cancer; studies in this area may, however, provide some
insights into the overall role of oral health in cancer. Tooth
loss appears to be a better indicator than probing as a marker
of lifetime oral health. Tooth loss or missing teeth has been
hypothesized to reflect an individual’s lifetime accumulation
of oral inflammation.28 In our study, we used reported his-
tory of dental status represented by number of teeth, oral
health indices, initial caries, decayed/missing/filled teeth and
need for periodontal treatment according to the involvement
of gingival pockets. Furthermore, we defined periodontitis as
a binary variable (no/yes) based on the procedure codes of
periodontitis treatment in the years 2001 and 2002, when we
collected data on patients’ oral health status. All the collected
data support the association between periodontitis and all-
cancer mortality, especially pancreatic cancer.
The main potential confounding factors between peri-
odontitis and cancer are tobacco, alcohol, socio-economic sta-
tus, diabetes, age, gender and ethnicity, along with genetic
and dietary factors.20 Among the potential confounders in
this study were socio-demographic characteristics, such as
age, sex and socio-economic status, which were available for
the entire study population. In addition, we used prescription
data to identify patients with diabetes, which is known to
affect the risk for both periodontitis and cancer. The study
was limited by the lack of information on smoking and alco-
hol use, which may confound the findings because both are
known risk factors of pancreatic cancer. We found a strong
Table 1. Basic characteristics of the study population of 68,273 patients (Continued)
Periodontitis treatment, N514,021 No periodontitis treatment, N554,252
14–18 2,911 (20.8) 8,960 (16.5)
19–23 3,305 (23.6) 8,260 (15.2)
24 3,317 (23.6) 8,354 (15.4)
Missing 1,496 (10.7) 18,049 (33.3)
CPI1
0–1 227 (1.6) 6,198 (11.4)
2 7,206 (51.4) 23,981 (44.2)
3–4 5,199 (37.1) 6,248 (11.5)
Missing 1,389 (9.9) 17,825 (32.9)
Number of healthy sextants2
0 9,850 (70.3) 17,896 (33.0)
1 1,597 (11.4) 5,227 (9.6)
2–4 897 (6.4) 7,387 (13.6)
5–6 288 (2.1) 5,917 (10.9)
Missing 1,389 (9.9) 17,825 (32.9)
Number of toothless sextants3
0 11,640 (83.0) 33,305 (61.4)
1–6 992 (7.1) 3,122 (5.7)
Missing 1,389 (9.9) 17,825 (32.9)
Diabetes, N (%) 703 (5.0) 1,842 (3.4)
Abbreviations: N, number of individuals; SD, standard deviation; I index, initial caries; D index, decayed teeth; DMF, decayed-missing-filled teeth;
CPI, need of periodontal treatment.
1Maximum value.
2Value at first visit.
3Minimum value.
Data from the patient register of the Public Dental Service of the City of Helsinki, individuals aged 29 years or more with at least one primary dental
health care visit between 1 January 2001 and 31 December 2002.
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positive association between periodontitis at baseline and
subsequent risk of fatal pancreatic cancer. However, at the
same time, we did not detect any association between peri-
odontitis and lung cancer, which may be interpreted to indi-
cate that confounding by smoking is probably not strong.
Altogether, additional studies are needed with more detailed
measurements of confounders such as smoking and alcohol
use in order to confirm these results.
Comparisons with other studies
Although the NNH of periodontitis for any cancer death
(1529) was relatively high, the commonness of periodontitis
makes it a risk factor with high public health relevance. In
Finland, the population segment aged 30 years and over was
3.6 million in 2015. Using the above-reported NNH figures
and assuming a 20% prevalence of periodontitis, we can
estimate that 470 cancer deaths occur every year due to peri-
odontitis. Between the years 2009 and 2013, there was on
average 11 743 cancer deaths per year in Finland, 1,004 of
these due to pancreas cancer. Using these assumptions, we
may calculate that about 4% of all cancer deaths are due to
periodontitis. In the European Union with ca. 377 million
people aged over 25 years, this means about 49,000 cancer
deaths using the above assumptions.
In USA, >50,000 people will be diagnosed with pancreatic
cancer this year, and because the disease is often not diag-
nosed until an advanced stage, <10% of those diagnosed will
still be alive in 5 years.29 In Finland, the number of pancre-
atic cancer cases was 577 in females and 539 in males in the
year 2013.30 The corresponding numbers of deaths for the
same year were 526 and 499. Pancreatic cancer is extremely
difficult to treat and little is known about its risk factors.
Table 2. Cancer mortality: number of deaths, person-time, crude mortality rates along with 95% confidence intervals and age-standardized
mortality rates for any cancer and by specific sites
Number of deaths
Person-time,
10,000 PY
Crude MR/10,000 PY
(95% CI) ASMR/10,000 PY
General population
ASMR1/10,000 PY
Lung cancer
Men 89 27.24 3.27 (2.62–4.02) 2.79 2.95
Women 72 39.16 1.84 (1.44–2.32) 1.63 1.46
Pancreatic cancer
Men 35 27.24 1.28 (0.89–1.79) 1.30 1.05
Women 40 39.16 1.02 (0.73–1.39) 0.90 0.71
Upper gastric cancer
Men 38 27.24 1.39 (0.99–1.91) 1.20 2.22
Women 26 39.16 0.66 (0.43–0.97) 0.35 0.92
Esophageal cancer
Men 18 27.24 0.66 (0.39–1.04) 0.51 0.36
Women 5 39.16 0.13 (0.04–0.30) 0.07 0.11
Gastric cancer
Men 20 27.24 0.73 (0.45–1.13) 0.69 0.45
Women 18 39.16 0.46 (0.27–0.73) 0.24 0.27
Liver cancer
Men 20 27.24 0.73 (0.45–1.13) 0.69 0.74
Women 18 39.16 0.46 (0.27–0.73) 0.32 0.21
Head and neck cancer
Men 12 27.24 0.44 (0.23–0.77) 0.17 0.34
Women 9 39.16 0.23 (0.11–0.44) 0.05 0.09
Breast cancer (women) 74 39.16 1.89 (1.48–2.37) 1.12 1.51
Prostate cancer 26 27.24 0.95 (0.62–1.40) 0.73 1.18
Any cancer
Men 353 27.24 12.96 (11.64–14.38) 11.10 11.80
Women 444 39.16 11.34 (10.31–12.44) 8.69 8.37
Abbreviations: PY, person-years; CI, confidence intervals; MR, mortality rate; ASMR, age-standardized mortality rate with weights according to the
World Standard Population.
1Based on cancer statistics from the Finnish Cancer Registry for 2008–2012 for Helsinki area.
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Recognition of periodontitis as an important risk factor is
therefore of great importance.
Studies to date indicate a positive correlation between
periodontitis and several forms of cancers and include some
assessment of potential confounding factors in different pop-
ulations. The most consistent increased risk was noted
between oral and esophageal cancers and periodontitis. Gas-
tric and pancreatic cancers showed an association in most
but not all studies. Lung, prostate, hematological and other
cancers were less consistently associated with periodontitis or
insufficient studies were conducted to determine a predictable
pattern.31
A few reports exist on the relationship between periodon-
tal disease and cancer mortality, with limited findings. Abnet
et al. explored the association between tooth loss and total
and cause-specific mortality, and found higher upper GI can-
cer mortality (RR 1.35, 1.14–1.59) in cohort of nearly 29,000
individuals over a follow-up period of 15 years.32 In addition,
a difference in the effect of tooth loss on upper GI cancer
mortality was noted between smokers and nonsmokers; the
risk of upper GI cancer associated with increased tooth loss
among male never-smokers was actually higher than that
observed in male ever-smokers. In this population, esopha-
geal, gastric cardia and noncardia cancers were responsible
for 51%, 23% and 10% of total cancer deaths, respectively.33
We did not detect association between periodontitis and
esophageal cancer. One reason may be low number of cases
(N5 23) that makes inference uncertain.
Cabrera et al. examined the relation between tooth loss
and cancer mortality in a prospective cohort of 1,462 women
in western Sweden over a 24-year follow-up. There was no
significant association between tooth loss and all-site cancer
morbidity or mortality in this study. It should be noted that
no association was reported between tooth loss and C-
reactive protein in this study.34 In a cohort study, rural Chi-
nese tooth loss (which occurs through poor dental hygiene)
was significantly associated with increased risk for total death
from cancer and from upper GI cancer.33 Hujoel et al.
showed an increased risk for 884 cancer deaths in 11,328
individuals with periodontitis.35 By contrast, in the cohort
study (n5 12 223) of Tu et al., there was no significantly
enhanced risk between cancer deaths (n5 549) and increased
number of missing teeth in Scotland. In addition, no evi-
dence of an association between lung cancer and tooth loss
was found, with or without adjustment for smoking.36 In the
male cohort study (n5 48,375) by Michaud et al. with a
median follow-up of 17.7 years and 5,720 incident cancer
cases, periodontal disease was associated with a small but sig-
nificant increase in overall cancer incidence and mortality,
and this increase persisted among never-smokers.37
A Japanese 12-year prospective study with 656 subjects
aged 80 years found an association between tooth loss and
increased orodigestive (including oral cavity and pharynx,
esophagus, stomach, pancreas, liver, colon, rectum and anus)
cancer mortality (HR: 1.06, 95% CI: 1.01–1.13) after
adjustment for sex and smoking status, although the causality
remains unclear.11
In the following cohort, studies suggest that periodontal
disease is a risk factor for pancreatic cancer mortality and
may play a role in the development of pancreatic cancer,
independent of other known risk factors such as smoking.
Hujoel et al. also observed an increased risk for 49 pancreatic
cancer deaths in 11,328 individuals with periodontitis in the
NHANES I population cancer association.35 In Finland, a sig-
nificant association between tooth loss and pancreatic cancer
(174 cases) was reported in a cohort study (between 1985
and 1997) of male smokers (n5 29,104).38 Michaud et al.
found an association between pancreatic cancer (216 cases)
and history of periodontal disease (48,375 males), with the
association being higher among nonsmokers after adjustment
for age, smoking, diabetes, body mass index and several die-
tary factors.39 Ahn et al. using the NHANES III data
(n5 12,605), reported a fourfold increase in risk of pancre-
atic cancer among those with severe periodontitis. In the
same study, elevated antibodies to the periodontitis pathogen
Porphyromonas gingivalis were associated with a threefold
increase risk of orodigestive cancer mortality, but a separate
examination of this periodontitis pathogen with pancreatic
cancer mortality could not be conducted due to insufficient
case numbers. Their study suggests P. gingivalis as a potential
etiological agent.12 The findings of Michaud et al. support this
study, and they showed in a large European prospective cohort
study (n5 821) that individuals with high levels of antibodies
against P. gingivalis had a twofold higher risk of pancreatic
cancer than individuals with lower levels of these antibodies.40
Furthermore, a recent study determined that people with
periodontitis-causing oral pathogens have a greater risk of sub-
sequently developing pancreatic cancer, showing that oral
microbiome dysbiosis preceded the development of pancreatic
cancer instead of developing after onset of cancer.41 All these
studies are in line with our results. Relative to these cohort
studies, our study provides more detailed information on oral
health and a more generalizable study population, including
both sexes and a wider age range.
Established risk factors in pancreatic cancer are type 2
diabetes, insulin resistance, cigarette smoking and obesity.39
The impact of diabetes mellitus on periodontitis has been
found to be independent of the major risk factor. Periodonti-
tis and related systemic inflammation have an additive effect
on the development of diabetic complications, probably via
exacerbation of insulin resistance.42 In our study, after further
adjustment for diabetes, the results showed an even stronger
association of periodontitis with increased risk of mortality
from pancreatic cancer and any cancer.
The associations between oral diseases and general health
have recently attracted much attention, and the World Health
Organization has recognized the importance of oral health
care in preventing fatal chronic diseases.43
Although validation by further prospective studies is
essential, early diagnosis of initial periodontal disease
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associated with preventive treatment of periodontal inflam-
mation44 may have a significant impact on reducing overall
incidence and prevalence of human cancers. Prevention and
treatment of periodontitis may thus have substantial implica-
tions for public health in terms of prevention and early diag-
nosis, reducing the morbidity and mortality associated with
human cancers.
Acknowledgements
The authors gratefully acknowledge the leading dentist Merja Auero, the
Public Dental Service of the City of Helsinki and the dentist TuomoMaisala,
Technical Assistant, for collecting the data from the patient register of the
Public Dental Service of the City of Helsinki. They also thank Statistics Fin-
land, the Finnish Social Insurance Institution and the Finnish Cancer Regis-
try. The funders had no role in study design, data collection, data analysis,
data interpretation or writing of the report.
References
1. Kassebaum NJ, Bernabe E, Dahiya M, et al.
Global burden of severe periodontitis in 1990–
2010. J Dent Res 2014;93:1045–53.
2. Pihlstrom BL, Michalowicz BS, Johnson NW.
Periodontal diseases. Lancet 2005;366:1809–20.
3. Lalla E, Papapanou PN. Diabetes mellitus and
periodontitis: a tale of two common interrelated
diseases. Nat Rev Endocrinol 2011;7:738–48.
4. D’Aiuto F, Parkar M, Andreou G, et al. Peri-
odontitis and systemic inflammation: control of
the local infection is associated with a reduction
in serum inflammatory markers. J Dent Res.
2004;83:156–60.
5. Tonetti MS, D’Aiuto F, Nibali L, et al. Treatment
of periodontitis and endothelial function. N Engl
J Med 2007;356:911–20.
6. Plummer M, de Martel C, Vignat J. Global bur-
den of cancers attributable to infections in 2012:
a synthetic analysis. Lancet Glob Health. 2016;4:
609–16.
7. Mantovani A, Allavena P, Sica A, et al. Cancer-
related inflammation. Nature 2008;454:436–44.
8. Tezal M, Sullivan MA, Hyland A, et al. Chronic
periodontitis and the incidence of head and neck
squamous cell carcinoma. Cancer Epidemiol Bio-
markers Prevent 2009;18:2406–12.
9. Meyer MS, Joshipura K, Giovannucci E, et al. A
review of the relationship between tooth loss,
periodontal disease, and cancer. Cancer Causes
Control 2008;19:895–907.
10. Moraes RC, de Dias FL, Figueredo Cm da S,
Fischer RG. Association between chronic peri-
odontitis and oral/oropharyngeal cancer. Braz
Dent J 2016;27:261–6.
11. Ansai T, Takata Y, Yoshida A, et al. Association
between tooth loss and orodigestive cancer mor-
tality in an 80-year-old community-dwelling Jap-
anese population: a 12-year prospective study.
BMC Public Health 2013;13:814
12. Ahn J, Segers S, Hayes RB. Periodontal disease,
Porphyromonas gingivalis serum antibody levels
and orodigestive cancer mortality. Carcinogenesis
2012;33:1055–8.
13. Grover V, Kapoor A, Sehgal K, et al. Chronic
inflammation and carcinogenesis – emerging role
of chronic inflammatory periodontal disease.
Cancer Res Front 2016;2:200–225.
14. Statistics Finland - Health - Causes of death
[Internet]. [cited 2016 Nov 7] Available from:
http://www.stat.fi/til/ksyyt/index_en.html
15. Overview of benefit programmes 2007. Finland:
Social Insurance Institution, 2007.
16. WHO | International Classification of Diseases
for Oncology, 3rd Edition (ICD-O-3) [Internet].
[cited 2014 Feb 25]; Available from: http://www.
who.int/classifications/icd/adaptations/oncology/
en/
17. Teppo L, Pukkala E, Lehtonen M. Data quality
and quality control of a population-based cancer
registry. Experience in Finland. Acta Oncol 1994;
33:365–9.
18. Korhonen P, Malila N, Pukkala E, et al. The
Finnish Cancer Registry as follow-up source of a
large trial cohort–accuracy and delay. Acta Oncol
2002;41:381–8.
19. Ainamo J, Barmes D, Beagrie G, et al. Develop-
ment of the World Health Organization (WHO)
community periodontal index of treatment needs
(CPITN). Int Dent J 1982;32:281–91.
20. World Health Organization. Oral health surveys:
basic methods. Enque^tes sur la sante bucco-
dentaire: methodes fondamentales [Internet] 1997
[cited 2016 Nov 7]; Available from: http://www.
who.int/iris/handle/10665/41905
21. R Core Team. R: A language and environment
for statistical computing [Internet]. Vienna,
Austria: R Foundation for Statistical Computing,
2016. Available from: https://www.R-project.org/
22. Plummer M, Carstensen B. Lexis: an R class for
epidemiological studies with long-term follow-up.
J Stat Soft 2011;38:1–12.
23. Boshuizen HC, Feskens EJ. Fitting additive Pois-
son models. Epidemiol Perspect Innov 2010;7:4
24. Carstensen B, Plummer M, Laara MH, et al. Epi:
A package for statistical analysis in epidemiology.
[Internet]. 2008. Available from: http://www.pub-
health.ku.dk/bxc/Epi/
25. Widstr€om E, Nihtil€a A. Aikuisten hammashoito
suurten ja keskisuurten kaupunkien terveyske-
skuksissa. 2004 [cited 2016 Dec 19]; Available
from: http://www.julkari.fi/handle/10024/100487
26. Irfan UM, Dawson DV, Bissada NF. Epidemiol-
ogy of periodontal disease: a review and clinical
perspectives. J Int Acad Periodontol 2001;3:14–21.
27. Papapanou PN. Periodontal diseases: epidemiol-
ogy. Ann Periodontol 1996;1:1–36.
28. Liljestrand JM, Havulinna AS, Paju S, M€annist€o
S, Salomaa V, Pussinen PJ. Missing teeth predict
incident cardiovascular events, diabetes, and
death. J Dent Res. 2015;0022034515586352.
29. Cancer of the Pancreas - SEER Stat Fact Sheets
[Internet]. [cited 2016 Nov 7]; Available from:
http://seer.cancer.gov/statfacts/html/pancreas.html
Abnet CC, Qiao YL, Mark SD, Dong ZW, Taylor
PR, Dawsey SM. Prospective study of tooth loss
and incident esophageal and gastric cancers in
China. Cancer Causes Control 2001;12:847–54.
30. Cancer statistics - Cancer Society of Finland
[Internet]. [cited 2016 Nov 7];Available from:
http://www.cancer.fi/syoparekisteri/en/statistics/
cancer-statistics/
31. Fitzpatrick SG, Katz J, The association between
periodontal disease and cancer: A review of the
literature. J Dent 2003;13:312–95.
32. Abnet CC, Qiao Y-L, Dawsey SM, et al. Tooth
loss is associated with increased risk of total
death and death from upper gastrointestinal can-
cer, heart disease, and stroke in a Chinese
population-based cohort. Int J Epidemiol 2005;34:
467–74.
33. Abnet CC, Qiao YL, Mark SD, et al. Prospective
study of tooth loss and incident esophageal and
gastric cancers in China. Cancer Causes Control
2001;12:847–54.
34. Cabrera C, Hakeberg M, Ahlqwist M, et al. Can
the relation between tooth loss and chronic dis-
ease be explained by socio-economic status? A
24-year follow-up from the population study of
women in Gothenburg, Sweden. Eur J Epidemiol
2005;20:229–36.
35. Hujoel PP, Drangsholt M, Spiekerman C, et al.
An exploration of the periodontitis-cancer associ-
ation. Ann Epidemiol 2003;13:312–6.
36. Tu Y-K, Galobardes B, Smith GD, et al. Associa-
tions between tooth loss and mortality patterns in
the Glasgow Alumni Cohort. Heart 2007;93:
1098–103.
37. Michaud DS, Liu Y, Meyer M, et al. Periodontal
disease, tooth loss, and cancer risk in male health
professionals: a prospective cohort study. Lancet
Oncol 2008;9:550–8.
38. Stolzenberg-Solomon RZ, Dodd KW, Blaser MJ,
et al. Tooth loss, pancreatic cancer, and Helico-
bacter pylori. Am J Clin Nutr 2003;78:176–81.
39. Michaud DS, Joshipura K, Giovannucci E, et al.
A prospective study of periodontal disease and
pancreatic cancer in US male health professionals.
J Natl Cancer Inst 2007;99:171–5.
40. Michaud DS, Izard J, Wilhelm-Benartzi CS, et al.
Plasma antibodies to oral bacteria and risk of
pancreatic cancer in a large European prospective
cohort study. Gut 2013;62:1764–70.
41. Fan X, Alekseyenko AV, Wu J, et al. Human oral
microbiome and prospective risk for pancreatic
cancer: a population-based nested case-control
study. Gut. 2016;
42. Preshaw PM, Alba AL, Herrera D, et al. Peri-
odontitis and diabetes: a two-way relationship.
Diabetologia 2012;55:21–31.
43. Petersen PE, Yamamoto T. Improving the oral
health of older people: the approach of the WHO
Global Oral Health Prpgramme. Community Dent
Oral Epidemiol 2005;33:81–92.
44. Sorsa T, Gieselmann D, Arweiler NB, et al. A
quantitative point-of-care test for periodontal and
dental peri-implant diseases. Nat Rev Dis Primers
2017;3:17069.
C
an
ce
r
E
pi
de
m
io
lo
gy
Heikkil€a et al. 2253
Int. J. Cancer: 142, 2244–2253 (2018) VC 2018 UICC
